|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Jan 1, 2023
|
FY2021
12 months to Jan 2, 2022
|
FY2020
12 months to Jan 3, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross (loss) profit | |||||
| Operating expenses | |||||
| Research and development expense | |||||
| Sales, general and administrative | |||||
| Restructuring charges | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other expense, net | |||||
| Interest expense | |||||
| Interest income | |||||
| Gain on extinguishment of debt | |||||
| Other, net | |||||
| Other expense, net | |||||
| Loss before income taxes and equity in losses of unconsolidated investees | |||||
| (Provision for) benefits from income taxes | |||||
| Equity in losses of unconsolidated investees | |||||
| Net loss | |||||
| Net loss (income) attributable to noncontrolling interests | |||||
| Net loss attributable to stockholders | |||||
| Basic (USD per share) | |||||
| Diluted (USD per share) | |||||
| Weighted average shares used in loss per share computation: | |||||
| Basic (shares) | |||||
| Diluted (shares) | |||||
Loading...